SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
MSCI Inc. (MSCI) trades at a trailing P/E of 35.6, forward P/E of 28.1. Trailing earnings yield is 2.81%, forward earnings yield 3.56%. PEG 3.33.
Criteria proven by this page:
- VALUE (49/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 28.1 (down from trailing 35.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 3.33 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 2.81% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.56% as earnings recover.
- Analyst consensus target $666.57 (+22.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 75/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
49/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MSCI
Valuation Multiples
P/E (TTM)35.6
Forward P/E28.1
PEG Ratio3.33
Forward PEG1.13
P/B Ratio-16.13
P/S Ratio13.01
EV/EBITDA24.3
Per Share Data
EPS (TTM)$15.58
Forward EPS (Est.)$19.44
Book Value / Share$-34.40
Revenue / Share$40.62
FCF / Share$20.08
Yields & Fair Value
Earnings Yield2.81%
Forward Earnings Yield3.56%
Dividend Yield1.34%
SharesGrow IV$500.93 (-8.2%)
Analyst Target$666.57 (+22.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
29.0 |
0.89 |
23.81 |
6.57 |
1.27% |
| 2017 |
37.6 |
1.60 |
28.51 |
8.97 |
1.05% |
| 2018 |
25.3 |
0.34 |
-77.20 |
8.96 |
1.33% |
| 2019 |
38.8 |
2.72 |
-284.87 |
14.03 |
1.02% |
| 2020 |
62.1 |
7.81 |
-84.34 |
22.05 |
0.66% |
| 2021 |
69.6 |
3.11 |
-309.25 |
24.74 |
0.60% |
| 2022 |
43.1 |
1.92 |
-37.27 |
16.70 |
0.99% |
| 2023 |
39.1 |
1.15 |
-60.76 |
17.77 |
0.98% |
| 2024 |
42.6 |
-17.09 |
-50.24 |
16.54 |
1.08% |
| 2025 |
36.8 |
3.48 |
-16.68 |
14.12 |
1.26% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.70 |
$1.15B |
$260.86M |
22.7% |
| 2017 |
$3.31 |
$1.27B |
$303.97M |
23.9% |
| 2018 |
$5.66 |
$1.43B |
$507.89M |
35.4% |
| 2019 |
$6.59 |
$1.56B |
$563.65M |
36.2% |
| 2020 |
$7.12 |
$1.7B |
$601.82M |
35.5% |
| 2021 |
$8.70 |
$2.04B |
$725.98M |
35.5% |
| 2022 |
$10.72 |
$2.25B |
$870.57M |
38.7% |
| 2023 |
$14.39 |
$2.53B |
$1.15B |
45.4% |
| 2024 |
$14.05 |
$2.86B |
$1.11B |
38.8% |
| 2025 |
$15.56 |
$3.13B |
$1.2B |
38.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$19.45 |
$19.08 – $19.61 |
$3.45B |
$3.42B – $3.51B |
10 |
| 2027 |
$21.99 |
$21.70 – $22.17 |
$3.74B |
$3.69B – $3.77B |
10 |
| 2028 |
$24.89 |
$24.15 – $25.84 |
$4.06B |
$4.06B – $4.06B |
5 |
| 2029 |
$27.67 |
$27.20 – $28.32 |
$4.35B |
$4.3B – $4.43B |
1 |
| 2030 |
$30.98 |
$30.45 – $31.71 |
$4.7B |
$4.64B – $4.78B |
1 |
